Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 84 73096 64989 399107 611--
Entreprise Value (EV)1 151 578159 446146 192157 669149 331144 201
P/E ratio -115x14,6x12,5x12,9x12,0x11,0x
Yield 3,05%2,69%2,93%2,45%2,49%2,55%
Capitalization / Revenue 0,44x0,38x0,33x0,38x0,37x0,35x
EV / Revenue 0,78x0,62x0,54x0,56x0,51x0,47x
EV / EBITDA 11,9x9,23x8,07x8,56x7,67x7,09x
Price to Book 1,17x1,51x1,29x1,22x1,24x1,14x
Nbr of stocks (in thousands) 1 293 1991 300 9641 308 9131 319 575--
Reference price (USD) 65,574,368,381,681,681,6
Announcement Date 02/20/201902/12/202002/16/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 194 579256 776268 706282 789294 591307 116
EBITDA1 12 73417 27418 10818 42219 48120 351
Operating profit (EBIT)1 10 25515 33916 00816 14016 95917 716
Operating Margin 5,27%5,97%5,96%5,71%5,76%5,77%
Pre-Tax Profit (EBT)1 1 4068 9979 77011 42912 37113 033
Net income1 -5946 6347 1798 3989 0869 842
Net margin -0,31%2,58%2,67%2,97%3,08%3,20%
EPS2 -0,575,085,466,336,817,38
Dividend per Share2 2,002,002,002,002,032,08
Announcement Date 02/20/201902/12/202002/16/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 69 55469 09772 61670 51372 05072 654
EBITDA1 3 4944 7445 4314 3094 0464 838
Operating profit (EBIT)1 2 9454 2054 8873 7723 5414 282
Operating Margin 4,23%6,09%6,73%5,35%4,91%5,89%
Pre-Tax Profit (EBT)1 1 2252 9703 7352 4982 3662 948
Net income1 9732 2232 7831 8951 6902 265
Net margin 1,40%3,22%3,83%2,69%2,35%3,12%
EPS2 0,741,682,101,441,311,70
Dividend per Share ------
Announcement Date 02/16/202105/04/202108/04/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 66 84862 79756 79350 05841 72036 590
Net Cash position1 ------
Leverage (Debt / EBITDA) 5,25x3,64x3,14x2,72x2,14x1,80x
Free Cash Flow1 6 82810 39113 42810 42711 27011 757
ROE (Net Profit / Equities) 15,4%15,1%14,8%12,7%13,5%12,6%
Shareholders' equity1 -3 84643 80948 51066 14267 14378 373
ROA (Net Profit / Asset) 5,08%4,41%4,35%4,20%4,33%4,90%
Assets1 -11 693150 315164 974199 943209 683200 854
Book Value Per Share2 55,849,153,067,065,871,8
Cash Flow per Share2 8,499,8512,19,3910,111,0
Capex1 2 0372 4572 4372 8802 8182 919
Capex / Sales 1,05%0,96%0,91%1,02%0,96%0,95%
Announcement Date 02/20/201902/12/202002/16/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 107 611 320 373
Net sales (USD) 268 706 000 000
Number of employees 256 500
Sales / Employee (USD) 1 047 587
Free-Float 75,6%
Free-Float capitalization (USD) 81 347 406 313
Avg. Exchange 20 sessions (USD) 482 461 468
Average Daily Capital Traded 0,45%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA